NVO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Fees and other income is the income earned by insurance companies other than providing insurances. Novo Nordisk A/S's fees and other income for the three months ended in Mar. 2014 was $3,763 Mil. Its fees and other income for the trailing twelve months (TTM) ended in Mar. 2014 was $15,228 Mil.
Novo Nordisk A/S's quarterly fees and other income increased from Sep. 2013 ($3,752 Mil) to Dec. 2013 ($3,960 Mil) but then declined from Dec. 2013 ($3,960 Mil) to Mar. 2014 ($3,763 Mil).
Novo Nordisk A/S's annual fees and other income increased from Dec. 2011 ($11,518 Mil) to Dec. 2012 ($13,911 Mil) and increased from Dec. 2012 ($13,911 Mil) to Dec. 2013 ($15,253 Mil).
Income earned by insurance companies other than providing insurances. It includes investing income, fees and interest income.
Novo Nordisk A/S Fees and Other Income for the trailing twelve months (TTM) ended in Mar. 2014 was 3752.19375219 (Jun. 2013 ) + 3752.46981339 (Sep. 2013 ) + 3960.21171747 (Dec. 2013 ) + 3763.04106548 (Mar. 2014 ) = $15,228 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Novo Nordisk A/S Annual Data
Novo Nordisk A/S Quarterly Data